Annual Meeting

Bringing immunopeptidomics to the bedside

Michal Bassani–Sternberg will speak at the ASBMB annual meeting’s Molecular & Cellular Proteomics session.
Brian O'Flynn
Feb. 9, 2022

Michal Bassani–Sternberg helps advance the study of cancer vaccines and adoptive T-cell therapies by developing methods to identify cancer biomarkers. This work largely is based on the proteins responsible for immune system regulation known as immunopeptides.

Michal Bassani–Sternberg

Her research crosses the threshold of benchtop research and clinical application, but Bassani–Sternberg’s career path has not been linear; drawn by a general interest in all things biology, she holds a master’s degree in plant physiology. She said she found this experience enriching, “but I wanted to study something more related to humans — diseases, cancer.”

Her Ph.D. work with Arie Admon at the Technion – Israel Institute of Technology got her in on the ground floor in the field of immunopeptidomics using mass spectrometry. This and her subsequent postdoctoral work with Matthias Mann at the Max Planck Institute of Biochemistry helped pave the way for identifying and implementing novel human leukocyte antigen peptides as targets for immunotherapy.

George Coukos recruited Bassani–Sternberg to the Ludwig Institute for Cancer Research in Lausanne in 2015 to help start a new mass spectrometry lab with a specialty in immunopeptidomics — a testament to her impact on the field. She subsequently was awarded the Pfizer Research Prize in 2021.

Now a newly minted assistant professor and group leader at the Ludwig and head of immunopeptidomics at the University Hospital of Lausanne, Bassani–Sternberg does not take for granted the team effort by postdocs and graduate students she mentors. “I learned a lot from being a student in both a small and a large lab,” she said, “like how you want your PI to interact with you.”

She advises early-career scientists to “choose a topic you are really passionate about — something you will still want to be doing years down the line.”

And while it is easy to compare ourselves to others, Bassani–Sternberg sees no value in this. “There will always be people who appear to be technically better, but if you have dedication and motivation, there is no real comparison.”

Finding the needle in a haystack

The immunopeptidome consists of the thousands of peptides displayed by the human leukocyte antigen, or HLA, that enable lymphocytes to scrutinize the health of cells. It’s an attractive target for developing personalized cancer immunotherapies. The HLA gene cluster, however, is the most polymorphic in the human genome, so detection levels of T cells specific for each antigen historically have been too low for clinical purposes.

Michal Bassani–Sternberg’s lab uses mass spectrometry techniques combined with genomics and transcriptomics to identify HLA binding peptides accurately. This work has been used in Lausanne in both a cancer vaccine program and an adoptive T-cell therapy program. Bassani–Sternberg’s team receives samples from cancer surgeries, analyzes them with proteogenomic approaches, and predicts targets that then are used to develop personalized cancer vaccines or to enrich antigen-specific T cells for T-cell therapies. Follow-up samples from patients are used to examine target efficacy. These bioinformatic techniques have broad implications for future treatment, including for melanoma and ovarian, colorectal and lung cancer.

Bassani-Sternberg's talk will take place on Monday, April 4 at the ASBMB annual meeting. Click here for more scheduling details.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Brian O'Flynn

Brian O'Flynn is a scientific writer at St. Jude Children's Research Hospital in Memphis.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Cedeño–Rosario and Kaweesa win research award
Member News

Cedeño–Rosario and Kaweesa win research award

Sept. 8, 2025

The award honors outstanding early-career scientists studying cancer, infectious disease and basic science.

ASBMB names 2026 award winners
Award

ASBMB names 2026 award winners

Sept. 5, 2025

Check out their lectures at the annual meeting in March in the Washington, D.C., metro area.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Castiglione and Ingolia win Keck Foundation grants
Member News

Castiglione and Ingolia win Keck Foundation grants

Sept. 1, 2025

They will receive at least $1 million of funding to study the biological mechanisms that underly birds' longevity and sequence–function relationships of intrinsically disordered proteins.

How undergrad research catalyzes scientific careers
Essay

How undergrad research catalyzes scientific careers

Aug. 27, 2025

Undergraduate research doesn’t just teach lab skills, it transforms scientists. For Antonio Rivera and Julissa Cruz–Bautista, joining a lab became a turning point, fostering critical thinking, persistence and research identity.

Simcox and Gisriel receive mentoring award
Member News

Simcox and Gisriel receive mentoring award

Aug. 25, 2025

They were honored for contributing their time, knowledge, energy and enthusiasm to mentoring postdocs in their labs.